Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 May 31;12(5):1363-1367.
doi: 10.21037/tcr-23-48. Epub 2023 Apr 14.

Long-term efficacy of immune checkpoint inhibitors with or without chemotherapy in recurrent or metastatic squamous cell carcinoma of the head and neck: a commentary on the 4-year follow-up of the KEYNOTE-048 trial

Daisuke Sano  1 , Nobuhiko Oridate  1
Affiliations
Editorial

Long-term efficacy of immune checkpoint inhibitors with or without chemotherapy in recurrent or metastatic squamous cell carcinoma of the head and neck: a commentary on the 4-year follow-up of the KEYNOTE-048 trial

Daisuke Sano et al. Transl Cancer Res. .
No abstract available

Keywords: Recurrent/metastatic squamous cell carcinoma of the head and neck; pembrolizumab; programmed cell death protein 1.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://tcr.amegroups.com/article/view/10.21037/tcr-23-48/coif). The authors have no conflicts of interest to declare.

Comment on

References

    1. Argiris A, Karamouzis MV, Raben D, et al. Head and neck cancer. Lancet 2008;371:1695-709. 10.1016/S0140-6736(08)60728-X - DOI - PMC - PubMed
    1. Forastiere AA, Metch B, Schuller DE, et al. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study. J Clin Oncol 1992;10:1245-51. 10.1200/JCO.1992.10.8.1245 - DOI - PubMed
    1. Vermorken JB, Mesia R, Rivera F, et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 2008;359:1116-27. 10.1056/NEJMoa0802656 - DOI - PubMed
    1. Ferris RL. Immunology and Immunotherapy of Head and Neck Cancer. J Clin Oncol 2015;33:3293-304. 10.1200/JCO.2015.61.1509 - DOI - PMC - PubMed
    1. Snyder A, Makarov V, Merghoub T, et al. Genetic basis for clinical response to CTLA-4 blockade in melanoma. N Engl J Med 2014;371:2189-99. 10.1056/NEJMoa1406498 - DOI - PMC - PubMed

LinkOut - more resources